SKU: SQ1717302

FOXO4-DRI 10mg

$235.00

Description

FOXO4-DRI is a synthetic, D-amino-acid-stabilized peptide that selectively disrupts the interaction between the transcription factor FOXO4 and p53 in senescent cells, triggering apoptosis and clearance of aged cells. Widely used in aging and regenerative medicine research, FOXO4-DRI has been shown to restore tissue homeostasis, improve organ function, and mitigate age-related phenotypes in preclinical models.


Sequence & Composition

  • Amino Acid Sequence:
    Ac-(D)Arg-(D)Arg-(D)Arg-(D)Arg-Thr-Leu-Ser-His-Lys-Glu-Leu-Arg-Ile-Arg-Leu-Pro

  • Molecular Formula: C₈₀H₁₂₂N₂₄O₂₀

  • Molecular Weight: ~2 219 Da


Research & Applications

  • Senolysis: Induces targeted apoptosis of senescent fibroblasts and endothelial cells, clearing senescent cell burden in vitro.

  • Tissue Rejuvenation: Restores function in aged muscle, kidney, and skin by reducing pro-inflammatory secretions and promoting regenerative pathways.

  • Regenerative Medicine: Used to study rejuvenation of aged stem cell niches and to evaluate combination therapies with chemotherapeutics.


Recommended Usage

  • In Vitro: 1–10 µM in cell culture assays to assess senescent cell clearance.

  • In Vivo (Rodent Studies): 5–20 mg/kg via intraperitoneal injection, administered per experimental protocol.

  • Solubility: Dissolve in sterile water or PBS; gentle warming (~37 °C) may aid dissolution.


Packaging & Storage

  • Packaging: 10 mg amber glass vial with desiccant.

  • Shelf Life: Up to 12 months unopened.

  • Storage Conditions: Store at –20 °C; protect from light and moisture; avoid repeated freeze–thaw cycles.


For laboratory research use only. Not for human or veterinary consumption.


References

  1. Baar MP et al., “Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging,” Cell. 2017;171(1):155–169. https://pubmed.ncbi.nlm.nih.gov/28985509

  2. Daussy C et al., “Senolytic peptides refine treatments for aging‐related diseases,” Sci Transl Med. 2022;14(642):eabo6869. https://pubmed.ncbi.nlm.nih.gov/35144956

Reviews

There are no reviews yet.

Be the first to review “FOXO4-DRI 10mg”

Your email address will not be published. Required fields are marked *

FAQ

Research peptides are short chains of amino acids used in scientific and medical research. They are not approved for human consumption or therapeutic use but are studied for their potential biological effects.

Yes. Reverse Peptides offers 99% puritythird-party tested, and USA-made peptides. Our products are backed by quality assurance and a loyal base of researchers

Most peptides should be stored in a cool, dry place. Lyophilized powders are typically stable at room temperature but should be refrigerated for long-term storage. Always refer to the product label.

We accept major credit/debit cards and secure online payment options. All transactions are encrypted and secure.

No. Since our peptides are sold strictly for laboratory research purposes, no prescription is required. However, buyers must be qualified researchers or institutions.